Ironwood Pharmaceuticals

company in Cambridge, United States

IRWD Nasdaq ISIN US46333X1081 SEC CIK 1446847 LEI 549300PC8MR6QHH6P296
Follow Ironwood Pharmaceuticals Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $133M +9% vs same quarter last year
Net income $59.8M +49.3% vs same quarter last year
EPS, diluted $0.36 +56.5% vs same quarter last year
Operating cash flow $67.4M +41.6% vs same quarter last year
Revenue by quarter
$90.5M
$41.1M
$85.2M
$122.1M
$47.7M
$106.5M
$113M
$133M
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income15 fiscal years
  • Revenue
  • Net income
−$1.5B−$1B−$500M$0$500M$1BFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearRevenueNet income
FY25$296.2M$24M
FY24$351.4M$880K
FY23$442.7M−$1B
FY22$410.6M$175.1M
FY21$413.8M$528.4M
FY20$389.5M$106.2M
FY19$428.4M$21.5M
FY18$346.6M−$282.4M
FY17$298.3M−$116.9M
FY16$274M−$81.7M
FY15$149.6M−$142.7M
FY14$76.4M−$189.6M
FY13$22.9M−$272.8M
FY12$150.2M−$72.6M
FY11$65.9M−$64.9M
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
−1500%−1000%−500%0%500%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearGross marginOperating marginNet margin
FY25-33.3%8.1%
FY24-26.5%0.3%
FY23-−213.5%−233%
FY22-61%42.6%
FY21-56.1%127.7%
FY2099.2%36.7%27.3%
FY1994.4%28%5%
FY1890.6%−43.5%−81.5%
FY1793.6%−5.2%−39.2%
FY1699.3%−18.9%−29.8%
FY15100%−68.3%−95.4%
FY1493.1%−221.6%−248.1%
FY1368.5%−1101.4%−1192.3%
FY1299.4%−48.4%−48.3%
FY11-−100.4%−98.5%
Free cash flowOperating cash flow minus capital expenditure
−$400M−$200M$0$200M$400MFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearFree cash flow
FY25$127M
FY24$103.4M
FY23$183.2M
FY22$273.6M
FY21$261.6M
FY20$167M
FY19$3.5M
FY18−$71.2M
FY17−$103.6M
FY16−$30.1M
FY15−$111M
FY14−$159.1M
FY13−$282.9M
FY12−$83.6M
FY11−$84.9M
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Ironwood Pharmaceuticals
  • Healthcare median
−1500%−1000%−500%0%500%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearIronwood PharmaceuticalsHealthcare median
FY258.1%−30.6%
FY240.3%−47%
FY23−233%−58%
FY2242.6%−80.4%
FY21127.7%−71.8%
FY2027.3%−62.2%
FY195%−46.2%
FY18−81.5%−49.6%
FY17−39.2%−45.9%
FY16−29.8%−36%
FY15−95.4%−37.8%
FY14−248.1%−35.5%
FY13−1192.3%−37.1%
FY12−48.3%−29.1%
FY11−98.5%−27.9%